322 related articles for article (PubMed ID: 31696961)
1. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
[TBL] [Abstract][Full Text] [Related]
3. Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
Christensen B; Hanauer SB; Gibson PR; Turner JR; Hart J; Rubin DT
J Crohns Colitis; 2020 Oct; 14(10):1345-1353. PubMed ID: 32267926
[TBL] [Abstract][Full Text] [Related]
4. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
[TBL] [Abstract][Full Text] [Related]
5. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
Narula N; Aruljothy A; Alshahrani AA; Fadida M; Al-Saedi M; Marshall JK; Rubin DT; Christensen B
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1676-1682. PubMed ID: 33131108
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
[TBL] [Abstract][Full Text] [Related]
9. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
[TBL] [Abstract][Full Text] [Related]
10. A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials.
Li K; Strauss R; Marano C; Greenbaum LE; Friedman JR; Peyrin-Biroulet L; Brodmerkel C; De Hertogh G
J Crohns Colitis; 2019 Aug; 13(8):1025-1035. PubMed ID: 30721964
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.
Bessissow T; Lemmens B; Ferrante M; Bisschops R; Van Steen K; Geboes K; Van Assche G; Vermeire S; Rutgeerts P; De Hertogh G
Am J Gastroenterol; 2012 Nov; 107(11):1684-92. PubMed ID: 23147523
[TBL] [Abstract][Full Text] [Related]
12. Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
Kevans D; Kirsch R; Dargavel C; Kabakchiev B; Riddell R; Silverberg MS
Inflamm Bowel Dis; 2020 Oct; 26(11):1722-1729. PubMed ID: 31883337
[TBL] [Abstract][Full Text] [Related]
13. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
Bessissow T; Kron CM; Marcus V; Lemieux C; Laneuville J; Afif W; Wild G; Lakatos PL; Brassard P; Bitton A
Am J Gastroenterol; 2022 Oct; 117(10):1632-1638. PubMed ID: 35862833
[TBL] [Abstract][Full Text] [Related]
14. Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission.
Kaneshiro M; Takenaka K; Suzuki K; Fujii T; Hibiya S; Kawamoto A; Motobayashi M; Shimizu H; Nagahori M; Saito E; Okamoto R; Ohtsuka K; Watanabe M
Aliment Pharmacol Ther; 2021 Apr; 53(8):900-907. PubMed ID: 33645736
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients With Ulcerative Colitis.
Takenaka K; Ohtsuka K; Fujii T; Negi M; Suzuki K; Shimizu H; Oshima S; Akiyama S; Motobayashi M; Nagahori M; Saito E; Matsuoka K; Watanabe M
Gastroenterology; 2020 Jun; 158(8):2150-2157. PubMed ID: 32060000
[TBL] [Abstract][Full Text] [Related]
16. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
17. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
Seong G; Song JH; Kim JE; Kim TJ; Kim ER; Hong SN; Chang DK; Kim SH; Ha SY; Kim YH
Inflamm Bowel Dis; 2023 Feb; 29(2):238-244. PubMed ID: 35396998
[TBL] [Abstract][Full Text] [Related]
18. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
Calafat M; Lobatón T; Hernández-Gallego A; Mañosa M; Torres P; Cañete F; Cabré E; Ojanguren I; Domènech E
Dig Liver Dis; 2017 Dec; 49(12):1327-1331. PubMed ID: 28958412
[TBL] [Abstract][Full Text] [Related]
19. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
